BioLM
PrivateLast Round
Pre Seed
Mar 13, 2023
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BioLM operates in Healthcare & Life Sciences and is based in Shingle Springs, California. Its latest recorded funding round was a Pre Seed round in March 2023.
BioLM is a business and productivity software company that has developed a biological algorithm-based platform designed to run protein and DNA sequence classifiers, inference models, and custom de novo sequence generators.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLM Comparables
Compare BioLM with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 310.ai | 92% | |
| Chan Zuckerberg Biohub | 87% | |
| Synthesize Bio | 87% |
For institutional investors. Book with your work email.
BioLM Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioLM Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 2048 Ventures | Pre Seed |
| Nvidia Inception | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2026
Hiring one role, representing 25% of current headcount.
- Mar 13, 2023
Led by 2048 Ventures
For institutional investors. Book with your work email.
BioLM Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioLM's valuation, stock price, and market status.
Is BioLM a public or private company?
BioLM is a private company.
What is the current stock price of BioLM?
BioLM is a private company, so its shares have no public market price. Caplight tracks BioLM's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioLM worth (valuation)?
Valuation information for BioLM is not publicly available.
Can I buy BioLM stock?
BioLM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioLM's last funding round?
BioLM's most recent funding round was Pre Seed on March 13, 2023.
Who are the main investors in BioLM?
Key investors in BioLM include 2048 Ventures.
Will BioLM IPO soon?
No public IPO plans have been announced for BioLM.
How can I track BioLM secondary market activity?
Caplight tracks bids, offers, and trades in BioLM's shares on secondary markets.